Electromed Inc (ELMD)

Currency in USD
18.82
-0.01(-0.05%)
Closed·
After Hours
18.82-0.07(-0.37%)
·
ELMD Scorecard
Full Analysis
Management has been aggressively buying back shares
ELMD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
18.7019.06
52 wk Range
13.7435.56
Key Statistics
Prev. Close
18.83
Open
19.03
Day's Range
18.7-19.06
52 wk Range
13.74-35.56
Volume
38.35K
Average Volume (3m)
83.83K
1-Year Change
21.81%
Book Value / Share
5.14
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ELMD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
32.00
Upside
+70.03%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Electromed Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Neutral
Moving Averages
Strong Sell

Electromed Inc Company Profile

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Electromed Inc Earnings Call Summary for Q2/2025

  • Record net income of $2 million ($0.22 per diluted share), exceeding forecasts; revenue up 18.7% YoY to $16.3 million
  • Stock surged 8.6% in aftermarket trading to $31.71; company maintains 188.63% return over past year
  • Strong financial health with no debt, $16.2 million cash balance, and $35.5 million working capital
  • Company anticipates double-digit top-line growth and expanded operating leverage for upcoming quarters
  • Monitoring potential complementary drug treatments for bronchiectasis patients to bolster market position
Last Updated: 11/02/2025, 23:30
Read Full Transcript

Compare ELMD to Peers and Sector

Metrics to compare
ELMD
Peers
Sector
Relationship
P/E Ratio
22.0x−4.3x−0.5x
PEG Ratio
0.36−0.300.00
Price/Book
3.6x2.6x2.6x
Price / LTM Sales
2.6x4.2x3.2x
Upside (Analyst Target)
53.8%38.3%42.0%
Fair Value Upside
Unlock5.1%6.6%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 32.00
(+70.03% Upside)

Earnings

Latest Release
May 13, 2025
EPS / Forecast
0.21 / 0.21
Revenue / Forecast
15.70M / 15.80M
EPS Revisions
Last 90 days

ELMD Income Statement

People Also Watch

54.15
ALK
-0.33%
105.07
CRUS
+0.95%
142.50
FI
+1.83%
331.60
ZBRA
-0.92%
25.53
CNC
-4.95%

FAQ

What Stock Exchange Does Electromed Trade On?

Electromed is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Electromed?

The stock symbol for Electromed is "ELMD."

What Is the Electromed Market Cap?

As of today, Electromed market cap is 157.83M.

What Is Electromed's Earnings Per Share (TTM)?

The Electromed EPS (TTM) is 0.84.

When Is the Next Electromed Earnings Date?

Electromed will release its next earnings report on 01 Sept 2025.

From a Technical Analysis Perspective, Is ELMD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Electromed Stock Split?

Electromed has split 0 times.

How Many Employees Does Electromed Have?

Electromed has 174 employees.

What is the current trading status of Electromed (ELMD)?

As of 30 Jul 2025, Electromed (ELMD) is trading at a price of 18.82, with a previous close of 18.83. The stock has fluctuated within a day range of 18.70 to 19.06, while its 52-week range spans from 13.74 to 35.56.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.